Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Q Biomed Inc (QBIO)

Q Biomed Inc (QBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 17,759
  • Shares Outstanding, K 14,677
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,270 K
  • 60-Month Beta 3.94
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.52
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/22/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/19
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2000 unch
on 07/19/19
1.6500 -27.27%
on 06/28/19
-0.1100 (-8.40%)
since 06/19/19
3-Month
1.2000 unch
on 07/19/19
2.0000 -40.00%
on 05/16/19
-0.6300 (-34.43%)
since 04/18/19
52-Week
0.9000 +33.33%
on 12/31/18
3.3700 -64.39%
on 10/01/18
-1.1400 (-48.72%)
since 07/19/18

Most Recent Stories

More News
Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity

New York, New York--(Newsfile Corp. - June 24, 2019) - Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities...

QBIO : 1.2000 (-0.83%)
Latest Biotechnology Advancements may be Key to Unlock new Autism Treatments

According to the Centers for Disease Control, autism affects an estimated 1 in 59 children in the United States today. The Autism Speaks website defines the main problem for researchers/practitioners...

QBIO : 1.2000 (-0.83%)
GERN : 1.23 (-1.60%)
INSM : 22.14 (+1.19%)
PHAS : 10.03 (-3.28%)
CMRX : 3.69 (+1.10%)
Q BioMed's Diagnostic Kit Designed to Serve Unmet Need for 70 Million Glaucoma Sufferers

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Company Spotlight article on high profile biomedical...

QBIO : 1.2000 (-0.83%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.6841 (-1.38%)
TRLFF : 0.2340 (-8.34%)
AITB : 5.24 (+2.34%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.1200 (-4.07%)
ATEA : 5.9500 (+5.87%)
CWBHF : 15.5200 (-0.39%)
CVSI : 4.1200 (-1.90%)
DUOT : 0.7300 (+2.82%)
CRLBF : 8.6200 (-0.92%)
ARREF : 0.5835 (+10.09%)
CLOK : 0.8560 (-4.94%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.3200 (+3.23%)
HEOFF : 0.8510 (-8.00%)
MJARF : 1.2155 (-3.12%)
ALEAF : 0.8979 (+0.89%)
OTCM : 33.2000 (unch)
NUPMF : 1.8950 (+0.53%)
GLDLF : 0.7242 (-0.79%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3301 (-3.65%)
GBPT : 7.7500 (unch)
IMLFF : 0.2463 (-4.65%)
KSHB : 4.7000 (-4.67%)
CORVF : 1.7100 (-4.47%)
ELLXF : 2.7100 (+2.26%)
RSSS : 2.6900 (-0.37%)
ISYRF : 1.0340 (+17.51%)
FLUX : 0.9000 (-28.00%)
NWGI : 0.3300 (-7.04%)
QBIO : 1.2000 (-0.83%)
WIZD : 0.1700 (-8.11%)
MRMD : 1.6300 (unch)
GRWG : 4.1400 (+4.81%)
BRTI : 0.3000 (+18.11%)
GTBP : 0.2500 (+5.93%)
MRIC : 3.86 (+1.45%)
DYAI : 5.09 (-0.20%)
GTBIF : 9.1040 (-1.04%)
MTAFF : 0.8400 (-1.06%)
EMHTF : 1.6400 (-3.02%)
ITHUF : 2.8600 (+2.14%)
ALYE : 2.2500 (unch)
VTLR : 0.1096 (+1.01%)
ARHH : 1.2000 (+4.35%)
OWCP : 0.0108 (-13.60%)
STLHF : 0.6990 (+9.80%)
PPCB : 0.0068 (-9.33%)
ARTH : 0.3299 (+1.51%)
ACRGF : 14.0300 (-2.03%)
Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Company Spotlight article on high profile biomedical...

QBIO : 1.2000 (-0.83%)
Demand for New Glaucoma Therapies Has Greatest Potential to Drive Value for Q BioMed's Shareholders

NEW YORK, NY / ACCESSWIRE / February 8, 2019 / Q BioMed (OTCQB: QBIO) has announced that it is bringing innovation to the treatment of Glaucoma- the the leading cause of irreversible blindness globally....

QBIO : 1.2000 (-0.83%)
Q BioMed Responds to OTC Markets Request for Clarity on Investor Awareness Activity

Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities undertaken by the Company.

QBIO : 1.2000 (-0.83%)
Biotech Companies Introduce New Treatments as Concern Over Cancer Rises

Cancer is among one of the leading causes of death around the globe; namely, in 2018, there were a total estimated 18.1 million new cases worldwide. The International Agency for Research on Cancer (IARC)...

QBIO : 1.2000 (-0.83%)
CELG : 90.20 (-0.78%)
INCY : 80.54 (-0.95%)
SGEN : 75.07 (-2.05%)
CELGZ : 0.47 (-5.98%)
NKTR : 31.97 (-0.31%)
Biotechnology Companies See Growth in Optic Treatment Sectors

The vast number of people in need of medical treatment has grown tremendously over the years. Some cases are a result of environmental changes, yet others can be caused by genetics. Regardless, there is...

QBIO : 1.2000 (-0.83%)
AERI : 23.12 (-2.12%)
NVS : 93.56 (-0.74%)
VSTM : 1.43 (-10.06%)
AXSM : 24.85 (-1.78%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

NEW YORK , Feb. 5, 2019 /PRNewswire/ --  www.FinancialBuzz.com , a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with...

QBIO : 1.2000 (-0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade QBIO with:

Key Turning Points

2nd Resistance Point 1.4000
1st Resistance Point 1.3000
Last Price 1.2000
1st Support Level 1.1500
2nd Support Level 1.1000

See More

52-Week High 3.3700
Fibonacci 61.8% 2.4265
Fibonacci 50% 2.1350
Fibonacci 38.2% 1.8435
Last Price 1.2000
52-Week Low 0.9000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar